Article
CD54 is a surrogate marker of antigen presenting cell activation.
Cancer immunology, immunotherapy : CII - 1 Sept 2008
Sheikh N A, Jones L A
Abstract excerpt
There is no single universally accepted hallmark of antigen presenting cell (APC) activation. Instead a variety of methods are used to identify APCs and assess their activation state. These activation measures include phenotypic methods [e.g., assessing the increased expression of surface markers such as major histocompatability (MHC) class II] and functional assays (e.g., evaluating the enhanced ability to take...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
